EDITORIAL
Breast cancer screening: Helping patients navigate recommendations
First published: 20 April 2021
Correspondence
Sarah Martaindale, Breast Imaging, MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 1350, Houston, TX 77030, USA.
Email: [email protected]
No abstract is available for this article.
REFERENCES
- 1Castelo M, Brown Z, Schellenberg A, et al. Abnormal screens among non-mutation carriers in the High Risk Ontario Breast Screening Program. Breast J. 2021; 27(5). https://doi.org/10.1111/tbj.14185
- 2Monticciolo DL, Newell MS, Hendrick RE, et al. Breast cancer screening for average-risk women: recommendations from the ACR Commission on breast imaging. J Am Coll Radiol. 2017; 14: 1137-1143.
- 3Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015; 314: 1599-1614.
- 4Bevers TB, Helvie M, Bonaccio E, et al. Breast cancer screening and diagnosis, version 3.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018; 16(11): 1362-1389.
- 5Siu AL, U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016; 164(4): 279-296.
- 6Lee CS, Moy L, Friedewald SM, Sickles EA, Monticciolo DL. Harmonizing breast cancer screening recommendations: metrics and accountability. AJR. 2018; 210(2): 241-245.
- 7Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020.
- 8Lee TC, Reyna C, Shaughnessy E, Lewis JD. Screening of populations at high risk for breast cancer. J Surg Oncol. 2019; 120(5): 820-830.
- 9Tosteson ANA, Fryback DG, Hammond CS, et al. Consequences of false-positive screening mammograms. JAMA Intern Med. 2014; 174(6): 954-961.
